How to produce ‘marketable and profitable results for the company’: from viral interference to Roferon A
Crossref DOI link: https://doi.org/10.1007/s40656-019-0268-8
Published Online: 2019-07-30
Published Print: 2019-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Timmermann, Carsten http://orcid.org/0000-0003-1381-9579
Funding for this research was provided by:
Wellcome Trust (WT092782)
F. Hoffmann-La Roche
Text and Data Mining valid from 2019-07-30
Version of Record valid from 2019-07-30
Article History
Received: 1 February 2019
Accepted: 16 July 2019
First Online: 30 July 2019